Sen. Mark Pryor, D-Ark., introduced a bill that would authorize the Food and Drug Administration's National Center for Toxicological Research to conduct safety studies on the use of nanotech materials in medical devices, pharmaceuticals and biologics. The legislation would allot $25 million annually over five years for the program and give the NCTR the power to develop best practices for the nanotech sector.

Related Summaries